No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Industrial - Machinery
Fidia S.p.A., together with its affiliated entities, focuses on engineering, producing, and supplying advanced high-speed milling systems and computerized numerical control (CNC) machines. Their product range also incorporates specialized milling heads, accompanying software, and various peripheral devices. Among these accessories, the HMS system is engineered for precise measurement and compensation of geometric errors in continuous or indexed bi-rotary heads and roto-tilting tables. The TMSC device accurately determines tool length and diameter, in addition to verifying its overall geometry. The K5 tracer provides a seamless solution for continuous scanning of three-dimensional surfaces. Other components include user-friendly pushbutton panels, XPower digital drives that control axis and spindle movement, and I/O Line input/output modules. Fidia's extensive software suite features ViMill, an anti-collision safeguard; HiMonitor, which tracks machine operational status; and Velocity 5, a system designed to optimize axis control, thereby enhancing machine performance. The HiMill computer-aided manufacturing (CAM) software is dedicated to the fabrication of dies, models, and aerospace components. An intuitive user interface is offered through the Isograph solution, while procedure-PRX provides tailored automation capabilities. The company serves critical sectors such as the automotive, aerospace, and power generation industries. Fidia's global presence covers Italy, the wider European continent, Asia, and both North and South America. Established in 1974, Fidia S.p.A. maintains its corporate headquarters in San Mauro Torinese, Italy.
www.fidia.itNo one on the platform currently holds FDA.MI.
No tracked institution reports a position in FDA.MI as of their last filing.
No one on the platform has traded FDA.MI yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $51M | -16.6% | $-14.00 | $-14.00–$-14.00 | — | 1 |
| 2027 | $51M | +0.4% | $-20.00 | $-20.00–$-20.00 | — | 1 |
| 2028 | $49M | -3.9% | $-38.00 | $-38.00–$-38.00 | — | 1 |
| 2029 | $26M | -46.9% | $-98.00 | $-98.00–$-98.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| FDA.MIFidia S.p.A. | $0.01 | +0.00% | $11M | — |
| BSS.MIBiesse S.p.A. | $5.02 | -0.20% | $133M | — |
| DIB.MIDigital Bros S.p.A. | $13.16 | +1.23% | $189M | — |
| ELN.MIEL.En. S.p.A. | $15.97 | -0.93% | $1.3B | — |
| EM.MIEmak S.p.A. | $0.82 | +0.61% | $134M | — |
| GE.MIGefran S.p.A. | $11.95 | +0.00% | $170M | — |
Source: Financial Modeling Prep · peers by sector/industry